IMC Chicago
STIM icon

IMC Chicago’s Neuronetics STIM Stock Holding History

IMC Chicago’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$56.2K Sell
24,000
-17,300
-42% -$42.5K ﹤0.01% 6178
2026
Q2 		$53.7K Buy
+41,300
New +$60.1K ﹤0.01% 6151

Other funds holding STIM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
VestGen Advisors
VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

IMC Chicago's STIM Position: Q3 2026 in Review

IMC Chicago reduced its Neuronetics (STIM) stake by 29% in Q3 2026, selling an estimated $10.4K and leaving 10,316 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6301.

IMC Chicago first reported a position in STIM in Q1 2026 and has held it in 3 quarters since. The position peaked at $39.6K in Q1 2026. 21 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • IMC Chicago held 10,316 shares of Neuronetics worth $24.1K as of Q3 2026.
  • IMC Chicago sold 4,250 Neuronetics shares in Q3 2026, an estimated $10.4K.
  • Neuronetics made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #6301 holding.
  • IMC Chicago first reported a position in Neuronetics in Q1 2026 and has held it in 3 quarters since.
  • IMC Chicago's Neuronetics position peaked at $39.6K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.